USPTO 2015–2025 USPTO PatentsView US Corporation

Codexis, Inc.

USPTO PatentsView assignee record — 350 granted patents across 26 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).

350
Total patents granted
26
CPC technology areas
15.3
Avg claims per patent
+8%
5-year filing velocity

Portfolio overview

Codexis, Inc. has been granted 350 US utility patents between 2015 and 2025, placing Codexis, Inc. at rank #1,212 across all assignees tracked by PlainPatent. This portfolio spans 26 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.3 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a US Corporation, Codexis, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 52.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 182 grants, compared with 168 in the 2015–2019 window — a +8% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Codexis, Inc.'s 15.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 26 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Codexis, Inc. against peers pursuing similar technology classes.

How does Codexis compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Codexis holds 350 patents — placing it at rank #1,212 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

202530354045 20152016201720182019202020212022202320242025 34
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Codexis, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 38 10.9%
2016 36 10.3%
2017 37 10.6%
2018 30 8.6%
2019 27 7.7%
2020 40 11.4%
2021 36 10.3%
2022 26 7.4%
2023 21 6.0%
2024 25 7.1%
2025 34 9.7%

Which technologies does Codexis, Inc. patent most?

Top 15 of 26 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#1,212

Across all tracked assignees

Innovation Score

52.1 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Codexis, Inc. hold?
Codexis, Inc. holds 350 US granted patents filed between 2015 and 2025, spanning 26 technology areas.
What is Codexis, Inc.'s Innovation Score?
Codexis, Inc. has an Innovation Score of 52.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Codexis, Inc. focus on?
Codexis, Inc.'s top technology area is C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA) with 346 patents. The company has filed patents in 26 CPC subclasses total.
Is Codexis, Inc.'s patent filing rate increasing or decreasing?
Codexis, Inc.'s recent filing velocity is +8% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Codexis, Inc.'s patents?
Codexis, Inc.'s patents average 15.3 claims each. This falls within the standard range, providing solid legal coverage.
How is the Codexis, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope